PAVmed (PAVM) – Globe Newswire
-
PAVmed Announces Procedural Update on its Settlement of a Previously Disclosed Class Action Lawsuit
-
22nd Century Group Announces CFO Transition
-
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
-
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
-
Lucid Diagnostics Announces Pricing of Initial Public Offering
-
Lucid Diagnostics Announces Pricing of Initial Public Offering
-
PAVmed Acquires EsophaCap Manufacturer CapNostics LLC
-
Tim Baxter, Former CEO of Samsung Electronics North America and Global Technology Industry Leader, Joins PAVmed Board of Directors
-
PAVmed Subsidiary Lucid Diagnostics Completes European CE Mark Certification of its EsoGuard Esophageal DNA Test
-
PAVmed Launches Digital Health Company Veris Health Inc.
-
PAVmed Subsidiary Lucid Diagnostics Receives CE Mark Certification for its EsoCheck® Esophageal Cell Collection Device
-
PAVmed Receives European CE Mark Certification for its CarpX® Minimally Invasive Carpal Tunnel Device
-
Data Presented at Digestive Disease Week 2021 Support Clinical Utility of PAVmed Subsidiary Lucid Diagnostics’ EsoCheck and EsoGuard Technologies
-
PAVmed Provides Business Update and First Quarter 2021 Financial Results
-
PAVmed Subsidiary Lucid Diagnostics Announces Upcoming Presentation at Digestive Disease Week 2021
-
PAVmed Subsidiary Lucid Diagnostics Expands Commercial Leadership Team
-
PAVmed to Hold Business Update Conference Call on May 17, 2021
-
Dr. Jacque Sokolov Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors
-
Global Industry Executive Debbie White Joins PAVmed Board of Directors
-
PAVmed Chairman & CEO Lishan Aklog, M.D. named Top 50 Healthcare Technology CEO by Healthcare Technology Report
-
PAVmed to Present at the 20th Annual Needham Healthcare Conference
-
PAVmed to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
-
PAVmed Retires Convertible Debt
-
PAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., Elected to AdvaMed Board of Directors
-
PAVmed Announces Closing of its Public Offering of Common Stock
-
PAVmed Announces Pricing of $45 Million Public Offering of Common Stock
-
PAVmed Announces Proposed Public Offering of Common Stock
-
PAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial Results
-
PAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST
-
First U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmed’s CarpX® Device
-
PAVmed to Hold Business Update Conference Call on February 22, 2021
-
PAVmed Closes $13.4 Million Common Stock Registered Direct Offering Priced At-the-Market under Nasdaq Rules
-
PAVmed Announces Registered Direct Offering of its Common Stock Priced At-the-Market under Nasdaq Rules
-
PAVmed Closes Additional $8.1 Million Common Stock Registered Direct Offering
-
PAVmed Announces Pricing of Additional $8.1 Million Common Stock Registered Direct Offering
-
PAVmed Announces Registered Direct Offering of its Common Stock
-
PAVmed Reports Third Quarter 2020 Financial Results and Provides Business Update
-
PAVmed to Hold Business Update Conference Call on November 17, 2020
-
PAVmed to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference on September 15, 2020
-
PAVmed Reports Second Quarter 2020 Financial Results and Provides Business Update
-
ContraFect Reports Second Quarter 2020 Financial Results and Provides Business Update
-
PAVmed Secures $7 Million Convertible Note Financing
-
PAVmed to Hold Business Update Conference Call on August 18, 2020
-
PAVmed to Present at Maxim Group’s COVID-19 Webinar on July 16, 2020
-
PAVmed to Join the Russell 2000® and Russell 3000® Indexes
-
Founder and Former Chairman & CEO of Exact Sciences Stanley Lapidus Joins PAVmed Subsidiary Lucid Diagnostics as Strategic Advisor
-
ContraFect Announces Appointment of Lishan Aklog, M.D. to Board of Directors
-
PAVmed Subsidiary Lucid Diagnostics Receives Preliminary Payment Determination for EsoGuard™ Esophageal DNA Test
-
PAVmed Collaborates with Canon on DisappEAR™ Pediatric Ear Tubes
-
PAVmed Reports Preliminary First Quarter 2020 Financial Results and Provides Business Update
Back to PAVM Stock Lookup